Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Grifols, S.A Gross Profit 2012-2025 | GRFS

Grifols, S.A annual/quarterly gross profit history and growth rate from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Grifols, S.A gross profit for the quarter ending March 31, 2025 was $0.732B, a 22.97% increase year-over-year.
  • Grifols, S.A gross profit for the twelve months ending March 31, 2025 was $2.927B, a 13.37% increase year-over-year.
  • Grifols, S.A annual gross profit for 2024 was $3.024B, a 12% increase from 2023.
  • Grifols, S.A annual gross profit for 2023 was $2.7B, a 14.83% increase from 2022.
  • Grifols, S.A annual gross profit for 2022 was $2.351B, a 1.26% increase from 2021.
  
Grifols, S.A Annual Gross Profit
(Millions of US $)
2024 $3,024
2023 $2,700
2022 $2,351
2021 $2,322
2020 $2,576
2019 $2,622
2018 $2,421
2017 $2,432
2016 $2,116
2015 $2,144
2014 $2,259
2013 $1,883
2012 $1,710
2011 $1,900
Grifols, S.A Quarterly Gross Profit
(Millions of US $)
2025-03-31 $732
2024-09-30 $799
2024-06-30 $722
2023-06-30 $674
2023-03-31 $595
2022-06-30 $615
2021-06-30 $700
2019-06-30 $672
2018-06-30 $617
2017-06-30 $617
2017-03-31 $578
2016-12-31 $543
2016-09-30 $522
2016-06-30 $528
2016-03-31 $523
2015-12-31 $572
2015-09-30 $537
2015-06-30 $526
2015-03-31 $506
2014-12-31 $442
2014-09-30 $567
2014-06-30 $532
2014-03-31 $594
2013-12-31 $456
2013-09-30 $471
2013-06-30 $485
2013-03-31 $462
2012-12-31 $421
2012-09-30 $418
2012-06-30 $430
2012-03-31 $423
2011-12-31 $796
2011-09-30 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.205B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.901B 31.10
Zoetis (ZTS) United States $68.972B 25.73
Daiichi Sankyo, - (DSNKY) Japan $43.624B 22.19
Takeda Pharmaceutical (TAK) Japan $43.624B 8.68
Sandoz Group AG (SDZNY) Switzerland $19.765B 0.00
Merck (MKKGY) Germany $17.939B 14.85
Summit Therapeutics (SMMT) United States $16.896B 0.00
United Therapeutics (UTHR) United States $13.518B 11.96
Shionogi (SGIOY) Japan $12.590B 12.61
Neurocrine Biosciences (NBIX) United States $11.755B 40.26
IPSEN (IPSEY) France $9.548B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.512B 61.07
Stevanato Group S.p.A (STVN) Italy $7.183B 43.93
Madrigal Pharmaceuticals (MDGL) United States $6.280B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.189B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.702B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.930B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 10.00
Hypermarcas (HYPMY) Brazil $2.687B 17.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.278B 12.46
BioCryst Pharmaceuticals (BCRX) United States $2.061B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.752B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.639B 0.00
Guardian Pharmacy Services (GRDN) United States $1.527B 0.00
Indivior (INDV) United States $1.521B 6.45
Evotec AG (EVO) Germany $1.449B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
ARS Pharmaceuticals (SPRY) United States $1.188B 0.00
Ocular Therapeutix (OCUL) United States $1.104B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.061B 21.22
Enliven Therapeutics (ELVN) United States $0.976B 0.00
Collegium Pharmaceutical (COLL) United States $0.934B 5.04
Harrow (HROW) United States $0.922B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.824B 0.00
Cronos Group (CRON) Canada $0.794B 0.00
Ardelyx (ARDX) United States $0.785B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
AleAnna (ANNA) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.643B 0.00
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Regulus Therapeutics (RGLS) United States $0.543B 0.00
CytoDyn (CYDY) United States $0.532B 0.00
Bioventus (BVS) United States $0.523B 13.29
Savara (SVRA) United States $0.517B 0.00
Relay Therapeutics (RLAY) United States $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.471B 0.00
Altimmune (ALT) United States $0.462B 0.00
Zevra Therapeutics (ZVRA) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.424B 8.85
Theravance Biopharma (TBPH) Cayman Islands $0.421B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Oruka Therapeutics (ORKA) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.327B 8.83
Nature's Sunshine Products (NATR) United States $0.263B 24.29
Heron Therapeutics (HRTX) United States $0.262B 0.00
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.221B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.186B 0.00
Nanobiotix S.A (NBTX) France $0.183B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.169B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.162B 0.00
Inhibikase Therapeutics (IKT) United States $0.158B 0.00
4D Molecular Therapeutics (FDMT) United States $0.145B 0.00
Esperion Therapeutics (ESPR) United States $0.145B 0.00
Journey Medical (DERM) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.130B 0.00
Wellgistics Health (WGRX) United States $0.129B 0.00
Aclaris Therapeutics (ACRS) United States $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Profound Medical (PROF) Canada $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.115B 0.00
Larimar Therapeutics (LRMR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.111B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.105B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.089B 14.70
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.086B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Telomir Pharmaceuticals (TELO) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
Context Therapeutics (CNTX) United States $0.071B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Surrozen (SRZN) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Incannex Healthcare (IXHL) Australia $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00